Cancer risk in adherent users of polyurethane foam-containing CPAP devices for sleep apnoea

Footnotes

This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.

Frederic Gagnadoux reports consulting fees from NYXOAH, SEFAM, RESMED; lecture honoraria from CIDELEC, ASTEN SANTE, PHILIPS RESPIRONICS; payment for expert testimony from BOEHRINGER INGELHEIM; travel support from ASTEN SANTE, ACTELION; participation on advisory board for JAZZ PHARMACEUTICAL; receipt of equipment from INSPIRE; outside the submitted work.

Sandrine Launois reports lecture honoraria from Philips Respironics, outside the submitted work.

Sébastien Bailly reports consulting fees for methodology and statistical analyses from ISRS Pays de la Loire, outside the submitted work.

All other authors have nothing to disclose.